You are here: Industry Insights > Remdesivir

News List

Lymphoma drug, pralatrexate outperforms remdesivir against COVID-19: Study expresspharma
January 04, 2021
However, this chemotherapy drug can prompt significant side effects so immediate use for COVID-19 patients is not guaranteed, said researchers.
Remdesivir likely to be highly effective antiviral against SARS-CoV-2 worldpharmanews
December 16, 2020
The drug remdesivir is likely to be a highly effective antiviral against SARS-CoV-2, according to a new study by a team of UK scientists.
Anixa, OntoChem COVID-19 Therapy Demonstrates Comparable Potency to Remdesivir americanpharmaceuticalreview
December 15, 2020
Anixa Biosciences and OntoChem GmbH have verified one of their recently discovered compounds is similar in potency to remdesivir, the only approved anti-viral drug against SARS-Cov-2. As previously announced, Anixa and OntoChem had identified multiple ...
Baricitinib Receives EUA for Hospitalized Patients with COVID-19 americanpharmaceuticalreview
December 07, 2020
Eli Lilly and Company and Incyte announced the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for the distribution and emergency use of baricitinib to be used in combination with remdesivir in hospitalized adult ...
Almac Secures Grant for Remdesivir Manufacturing for COVID-19 americanpharmaceuticalreview
December 01, 2020
Almac Sciences has been awarded a grant of approximately $500,000 by the COVID-19 Therapeutics Accelerator towards developing cost effective, scalable processes for the production of the active pharmaceutical ingredient (API) of the drug remdesivir.
WHO takes off remdesivir from prequalification list of medicines for COVID-19 expresspharma
November 23, 2020
It is an official list of medicines used as a benchmark for procurement by developing countries.
Olumniant (barcitinab) from Eli Lilly gets EUA from US FDA for COVID-19 treatment expresspharma
November 20, 2020
The US Food and Drug Administration (USFDA) issued an emergency use authorisation (EUA) for the drug baricitinib, in combination with remdesivir, for the treatment of suspected or laboratory-confirmed COVID-19 in hospitalised adults and pediatric ...
Almac Gets Grant From COVID-19 Therapeutics Accelerator contractpharma
November 19, 2020
Almac Sciences has been awarded a grant of approximately $500,000 by the COVID-19 Therapeutics Accelerator towards developing cost effective, scalable processes for the production of the active pharmaceutical ingredient (API) of the drug remdesivir.
Differences in remdesivir efficacy due to trial variances, not drug, report says europeanpharmaceuticalreview
November 10, 2020
After remdesivir showed little effect against COVID-19 in the SOLIDARITY trial, a new report has suggested this is due to the structure of the study.
Disappointing SOLIDARITY results for remdesivir likely due to trial differences and not the drug: GlobalData expresspharma
November 06, 2020
The SOLIDARITY trial did show that large-scale international trials are possible during a pandemic with the possibility of drawing conclusions at a rapid pace, as soon as six months.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 14 15 Next page